MULTITEST CMI INJ
MULTITEST CMI INJ
Discontinued
DIN Number
01905023
Drug Class
Human
Market Date
Dec 31, 1992
Company
HC
aventis pasteur limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01905023
AIG Number0816000001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
V04CX OTHER DIAGNOSTIC AGENTS
Product Specifications
Dosage FormLiquid
Route of AdministrationSubcutaneous
AHFS Classification36:89.00*
Health Canada Classification
ACTIVE INGREDIENTS (8)
CANDIDA ALBICANS ANTIGENActive
Strength: 2000 UNIT / PCK
Monograph: CANDIDA ALBICANS ANTIGEN
DIPHTHERIA TOXOID ANTIGENActive
Strength: 1100000 UNIT / PCK
Monograph: DIPHTHERIA TOXOID ANTIGEN
GLYCERINEActive
Strength: 70 % / PCK
Monograph: GLYCERINE
PROTEUS MIRABILIS ANTIGENActive
Strength: 150 UNIT / PCK
Monograph: PROTEUS MIRABILIS ANTIGEN
STREPTOCOCCUS ANTIGEN GROUP CActive
Strength: 2000 UNIT / PCK
Monograph: STREPTOCOCCUS ANTIGEN GROUP C
TETANUS TOXOID ANTIGENActive
Strength: 550000 UNIT / PCK
Monograph: TETANUS TOXOID ANTIGEN
TRICHOPHYTON MENTAGROPHYTES ANTIGENActive
Strength: 150 UNIT / PCK
Monograph: TRICHOPHYTON MENTAGROPHYTES ANTIGEN
TUBERCULIN OLDActive
Strength: 300000 UNIT / PCK
Monograph: TUBERCULIN OLD